Masakazu Kondo

Ichihara, 2908551, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Chlorine-Enabled Double Borylation Strategy for π-Extended MR-TADF Emitters: From Synthetic Challenge to Benchmark OLEDs.

Chlorine-Enabled Double Borylation Strategy for π-Extended MR-TADF Emitters: From Synthetic Challenge to Benchmark OLEDs.

Journal: Angewandte Chemie (International ed. in English)

Published: October 09, 2025

Improving the TADF properties of deep-blue multiple-resonance emitters by strategic oxygen-sulfur replacement.

Improving the TADF properties of deep-blue multiple-resonance emitters by strategic oxygen-sulfur replacement.

Journal: Materials horizons

Published: October 08, 2025

Joint involvement patterns and patient-reported satisfaction in difficult-to-treat rheumatoid arthritis: results from the multicentre observational cohort, FRANK Registry.

Joint involvement patterns and patient-reported satisfaction in difficult-to-treat rheumatoid arthritis: results from the multicentre observational cohort, FRANK Registry.

Journal: Modern rheumatology

Published: August 04, 2025

Impact of orthopaedic surgery on quality of life in patients with rheumatoid arthritis: a retrospective study using the FRANK (Fukuoka rheumatoid arthritis Network) registry.

Impact of orthopaedic surgery on quality of life in patients with rheumatoid arthritis: a retrospective study using the FRANK (Fukuoka rheumatoid arthritis Network) registry.

Journal: Modern rheumatology

Published: April 08, 2025

Late-stage direct double borylation of B/N-based multi-resonance framework enables high-performance ultra-narrowband deep-blue organic light-emitting diodes.

Late-stage direct double borylation of B/N-based multi-resonance framework enables high-performance ultra-narrowband deep-blue organic light-emitting diodes.

Journal: Nature communications

Published: March 08, 2025

Characterization of patients with rheumatoid arthritis not using biologic/targeted synthetic disease-modifying drugs despite insufficient disease control: Another difficult-to-treat RA.

Characterization of patients with rheumatoid arthritis not using biologic/targeted synthetic disease-modifying drugs despite insufficient disease control: Another difficult-to-treat RA.

Journal: Modern rheumatology

Published: September 17, 2024

Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study.

Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study.

Journal: BMC rheumatology

Published: August 02, 2024

Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registry.

Cluster analysis identifies the differential impact of disease activity and severity on functional status and patient satisfaction in rheumatoid arthritis: the FRANK registry.

Journal: Clinical and experimental rheumatology

Published: June 16, 2024

Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.

Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.

Journal: Clinical rheumatology

Published: March 15, 2024

Accumulation and Phagocytosis of Fluorescently Visualized Macrophages Against Edwardsiella piscicida Infection in Established mpeg1.1-Transgenic Japanese Medaka Oryzias latipes.

Accumulation and Phagocytosis of Fluorescently Visualized Macrophages Against Edwardsiella piscicida Infection in Established mpeg1.1-Transgenic Japanese Medaka Oryzias latipes.

Journal: Marine biotechnology (New York, N.Y.)

Published: March 01, 2024

Efficient Deep-Blue Multiple-Resonance Emitters Based on Azepine-Decorated ν-DABNA for CIEy below 0.06.

Efficient Deep-Blue Multiple-Resonance Emitters Based on Azepine-Decorated ν-DABNA for CIEy below 0.06.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: February 26, 2024

Bright, efficient, and stable pure-green hyperfluorescent organic light-emitting diodes by judicious molecular design.

Bright, efficient, and stable pure-green hyperfluorescent organic light-emitting diodes by judicious molecular design.

Journal: Nature communications

Published: October 15, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026